(1) As used in this chapter, unless the context otherwise requires:(1) “Batch” means a single stock-keeping unit with common cannabinoid input or a hemp flower of the same varietal and harvested on the same date and manufactured during a defined cycle in such a way that it could be expected to be of a uniform character and should be designated as such;(2) “Dry weight” means the weight of plant material with a moisture content that does not exceed thirteen percent (13%);(3) “Hemp-derived cannabinoid”:(A) Means:(i) A cannabinoid other than delta-9 tetrahydrocannabinol, or an isomer derived from such cannabinoid, that is derived from hemp in a concentration of more than one-tenth of one percent (0.1%);(ii) A hemp-derived product containing delta-9 tetrahydrocannabinol in a concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis; or(iii) A hemp-derived product containing a total THC content or a total theoretical THC content of not more than three-tenths of one percent (0.3%) on a dry weight basis;(B) Includes, but is not limited to:(i) Delta-8 tetrahydrocannabinol;(ii) Delta-10 tetrahydrocannabinol;(iii) Hexahydrocannabinol; and(iv) Tetrahydrocannabivarin (THCv); and(C) Does not include:(i) Cannabichromene (CBC/CBCa/CBCv);(ii) Cannabicitran (CBT/CBTa);(iii) Cannabicyclol (CBL/CBLa);(iv) Cannabidiol (CBD/CBDa/CBDv/CBDp);(v) Cannabielsoin (CBE/CBEa);(vi) Cannabigerol (CBG/CBGa/CBGv/CBGm);(vii) Cannabinol (CBN/CBNa);(viii) Cannabivarin (CBV/CBVa);(ix) Hemp-derived feed products allowed under title 44, chapter 6;(x) Hemp-derived fiber, grain, or stalk; provided, that the product does not contain a hemp-derived cannabinoid in a concentration of more than three-tenths of one percent (0.3%) on a dry weight basis;(xi) Tetrahydrocannabinolic acid (THCa) in a concentration greater than three-tenths of one percent (0.3%) on a dry weight basis;(xii) Tetrahydrocannabiphorol (THCp);(xiii) A synthetic cannabinoid; or(xiv) A substance that is categorized as a Schedule I controlled substance on or after July 1, 2023, including a substance that may be identified in subdivision (3)(B);(4) “Hemp-derived cannabinoid product” or “HDCP”:(A) Means a product that contains or that is labeled as containing a hemp-derived cannabinoid and that is produced, marketed, or otherwise intended to be ingested orally, inhaled, or absorbed through the skin, including hemp and hemp plant parts, and any product that may contain a hemp-derived cannabinoid that is extracted from hemp plants or hemp plant parts; and(B) Includes:(i) Intermediate products intended for subsequent use as a component in a later finished HDCP; and(ii) Except as excluded under subdivision (3)(C)(x), harvested hemp and hemp plant parts, otherwise known as hemp flower;(5) “Manufacture” means to compound, blend, extract, infuse, cook, or otherwise make or prepare HDCPs, including the processes of extraction, infusion, packaging, repackaging, labeling, and relabeling of HDCPs;(6) “Proof of age” means a valid driver license or other government-issued identification card that contains a photograph of the person and confirms the person's age as twenty-one (21) years of age or older;(7) “Retailer” means a person that sells, markets, or advertises as a seller, provides samples with or without a fee or charge, or otherwise distributes to the public, with or without compensation, HDCPs for consumption and not for resale;(8) “Serving” means a quantity of an HDCP reasonably suitable for a single person's daily use;(9) “Supplier” means a person that:(A) Is located either inside or outside of this state and that sells HDCPs to wholesalers or to suppliers licensed under this chapter for repackaging or for resale, but not for consumption;(B) Manufactures hemp-derived cannabinoids or HDCPs in this state; or(C) Contracts for the manufacture of hemp-derived cannabinoids or HDCPs, whether located inside or outside of this state, and that sells finished, packaged HDCPs to wholesalers or to suppliers licensed under this chapter for resale and not for consumption;(10) “Synthetic cannabinoid” means a substance with an identical or substantially similar chemical structure to or the pharmacological activity of a cannabinoid, but that is not extracted from hemp or hemp plant parts or derived from hemp or hemp plant parts;(11) “Tetrahydrocannabinolic acid” or “THCa” is the precursor of delta-9 THC;(12) “THC” means a tetrahydrocannabinol, tetrahydrocannabinolic acid, a THC component, or any derivative thereof;(13) “THC component” means a naturally occurring cannabinoid component of industrial hemp or hemp;(14) “Total THC” means a hemp-derived cannabinoid or a combination of tetrahydrocannabinol, tetrahydrocannabinolic acid, a THC component, or a derivative thereof;(15) “Total theoretical tetrahydrocannabinol content” or “total theoretical THC content” is the maximum amount of possible delta-9 tetrahydrocannabinol if total conversion were to occur, calculated as the sum of the concentration of delta-9 tetrahydrocannabinol added to the amount of tetrahydrocannabinolic acid after such amount is multiplied by eight hundred seventy-seven thousandths (0.877) on a dry weight basis and reported to two (2) significant figures, and expressed in a mathematical formula as follows:Total theoretical THC = ([delta 9 THC] + ([THCa] x 0.877)); and(16) “Wholesaler” means a person that purchases finished and packaged for consumption HDCPs, not considered intermediate products still in the pre-packaging stage, from suppliers licensed under this chapter, or from other wholesalers licensed under this chapter, and that sells HDCPs for resale and not for consumption.
(1) “Batch” means a single stock-keeping unit with common cannabinoid input or a hemp flower of the same varietal and harvested on the same date and manufactured during a defined cycle in such a way that it could be expected to be of a uniform character and should be designated as such;
(2) “Dry weight” means the weight of plant material with a moisture content that does not exceed thirteen percent (13%);
(3) “Hemp-derived cannabinoid”:(A) Means:(i) A cannabinoid other than delta-9 tetrahydrocannabinol, or an isomer derived from such cannabinoid, that is derived from hemp in a concentration of more than one-tenth of one percent (0.1%);(ii) A hemp-derived product containing delta-9 tetrahydrocannabinol in a concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis; or(iii) A hemp-derived product containing a total THC content or a total theoretical THC content of not more than three-tenths of one percent (0.3%) on a dry weight basis;(B) Includes, but is not limited to:(i) Delta-8 tetrahydrocannabinol;(ii) Delta-10 tetrahydrocannabinol;(iii) Hexahydrocannabinol; and(iv) Tetrahydrocannabivarin (THCv); and(C) Does not include:(i) Cannabichromene (CBC/CBCa/CBCv);(ii) Cannabicitran (CBT/CBTa);(iii) Cannabicyclol (CBL/CBLa);(iv) Cannabidiol (CBD/CBDa/CBDv/CBDp);(v) Cannabielsoin (CBE/CBEa);(vi) Cannabigerol (CBG/CBGa/CBGv/CBGm);(vii) Cannabinol (CBN/CBNa);(viii) Cannabivarin (CBV/CBVa);(ix) Hemp-derived feed products allowed under title 44, chapter 6;(x) Hemp-derived fiber, grain, or stalk; provided, that the product does not contain a hemp-derived cannabinoid in a concentration of more than three-tenths of one percent (0.3%) on a dry weight basis;(xi) Tetrahydrocannabinolic acid (THCa) in a concentration greater than three-tenths of one percent (0.3%) on a dry weight basis;(xii) Tetrahydrocannabiphorol (THCp);(xiii) A synthetic cannabinoid; or(xiv) A substance that is categorized as a Schedule I controlled substance on or after July 1, 2023, including a substance that may be identified in subdivision (3)(B);
(A) Means:(i) A cannabinoid other than delta-9 tetrahydrocannabinol, or an isomer derived from such cannabinoid, that is derived from hemp in a concentration of more than one-tenth of one percent (0.1%);(ii) A hemp-derived product containing delta-9 tetrahydrocannabinol in a concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis; or(iii) A hemp-derived product containing a total THC content or a total theoretical THC content of not more than three-tenths of one percent (0.3%) on a dry weight basis;
(i) A cannabinoid other than delta-9 tetrahydrocannabinol, or an isomer derived from such cannabinoid, that is derived from hemp in a concentration of more than one-tenth of one percent (0.1%);
(ii) A hemp-derived product containing delta-9 tetrahydrocannabinol in a concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis; or
(iii) A hemp-derived product containing a total THC content or a total theoretical THC content of not more than three-tenths of one percent (0.3%) on a dry weight basis;
(B) Includes, but is not limited to:(i) Delta-8 tetrahydrocannabinol;(ii) Delta-10 tetrahydrocannabinol;(iii) Hexahydrocannabinol; and(iv) Tetrahydrocannabivarin (THCv); and
(i) Delta-8 tetrahydrocannabinol;
(ii) Delta-10 tetrahydrocannabinol;
(iii) Hexahydrocannabinol; and
(iv) Tetrahydrocannabivarin (THCv); and
(C) Does not include:(i) Cannabichromene (CBC/CBCa/CBCv);(ii) Cannabicitran (CBT/CBTa);(iii) Cannabicyclol (CBL/CBLa);(iv) Cannabidiol (CBD/CBDa/CBDv/CBDp);(v) Cannabielsoin (CBE/CBEa);(vi) Cannabigerol (CBG/CBGa/CBGv/CBGm);(vii) Cannabinol (CBN/CBNa);(viii) Cannabivarin (CBV/CBVa);(ix) Hemp-derived feed products allowed under title 44, chapter 6;(x) Hemp-derived fiber, grain, or stalk; provided, that the product does not contain a hemp-derived cannabinoid in a concentration of more than three-tenths of one percent (0.3%) on a dry weight basis;(xi) Tetrahydrocannabinolic acid (THCa) in a concentration greater than three-tenths of one percent (0.3%) on a dry weight basis;(xii) Tetrahydrocannabiphorol (THCp);(xiii) A synthetic cannabinoid; or(xiv) A substance that is categorized as a Schedule I controlled substance on or after July 1, 2023, including a substance that may be identified in subdivision (3)(B);
(i) Cannabichromene (CBC/CBCa/CBCv);
(ii) Cannabicitran (CBT/CBTa);
(iii) Cannabicyclol (CBL/CBLa);
(iv) Cannabidiol (CBD/CBDa/CBDv/CBDp);
(v) Cannabielsoin (CBE/CBEa);
(vi) Cannabigerol (CBG/CBGa/CBGv/CBGm);
(vii) Cannabinol (CBN/CBNa);
(viii) Cannabivarin (CBV/CBVa);
(ix) Hemp-derived feed products allowed under title 44, chapter 6;
(x) Hemp-derived fiber, grain, or stalk; provided, that the product does not contain a hemp-derived cannabinoid in a concentration of more than three-tenths of one percent (0.3%) on a dry weight basis;
(xi) Tetrahydrocannabinolic acid (THCa) in a concentration greater than three-tenths of one percent (0.3%) on a dry weight basis;
(xii) Tetrahydrocannabiphorol (THCp);
(xiii) A synthetic cannabinoid; or
(xiv) A substance that is categorized as a Schedule I controlled substance on or after July 1, 2023, including a substance that may be identified in subdivision (3)(B);
(4) “Hemp-derived cannabinoid product” or “HDCP”:(A) Means a product that contains or that is labeled as containing a hemp-derived cannabinoid and that is produced, marketed, or otherwise intended to be ingested orally, inhaled, or absorbed through the skin, including hemp and hemp plant parts, and any product that may contain a hemp-derived cannabinoid that is extracted from hemp plants or hemp plant parts; and(B) Includes:(i) Intermediate products intended for subsequent use as a component in a later finished HDCP; and(ii) Except as excluded under subdivision (3)(C)(x), harvested hemp and hemp plant parts, otherwise known as hemp flower;
(A) Means a product that contains or that is labeled as containing a hemp-derived cannabinoid and that is produced, marketed, or otherwise intended to be ingested orally, inhaled, or absorbed through the skin, including hemp and hemp plant parts, and any product that may contain a hemp-derived cannabinoid that is extracted from hemp plants or hemp plant parts; and
(B) Includes:(i) Intermediate products intended for subsequent use as a component in a later finished HDCP; and(ii) Except as excluded under subdivision (3)(C)(x), harvested hemp and hemp plant parts, otherwise known as hemp flower;
(i) Intermediate products intended for subsequent use as a component in a later finished HDCP; and
(ii) Except as excluded under subdivision (3)(C)(x), harvested hemp and hemp plant parts, otherwise known as hemp flower;
(5) “Manufacture” means to compound, blend, extract, infuse, cook, or otherwise make or prepare HDCPs, including the processes of extraction, infusion, packaging, repackaging, labeling, and relabeling of HDCPs;
(6) “Proof of age” means a valid driver license or other government-issued identification card that contains a photograph of the person and confirms the person's age as twenty-one (21) years of age or older;
(7) “Retailer” means a person that sells, markets, or advertises as a seller, provides samples with or without a fee or charge, or otherwise distributes to the public, with or without compensation, HDCPs for consumption and not for resale;
(8) “Serving” means a quantity of an HDCP reasonably suitable for a single person's daily use;
(9) “Supplier” means a person that:(A) Is located either inside or outside of this state and that sells HDCPs to wholesalers or to suppliers licensed under this chapter for repackaging or for resale, but not for consumption;(B) Manufactures hemp-derived cannabinoids or HDCPs in this state; or(C) Contracts for the manufacture of hemp-derived cannabinoids or HDCPs, whether located inside or outside of this state, and that sells finished, packaged HDCPs to wholesalers or to suppliers licensed under this chapter for resale and not for consumption;
(A) Is located either inside or outside of this state and that sells HDCPs to wholesalers or to suppliers licensed under this chapter for repackaging or for resale, but not for consumption;
(B) Manufactures hemp-derived cannabinoids or HDCPs in this state; or
(C) Contracts for the manufacture of hemp-derived cannabinoids or HDCPs, whether located inside or outside of this state, and that sells finished, packaged HDCPs to wholesalers or to suppliers licensed under this chapter for resale and not for consumption;
(10) “Synthetic cannabinoid” means a substance with an identical or substantially similar chemical structure to or the pharmacological activity of a cannabinoid, but that is not extracted from hemp or hemp plant parts or derived from hemp or hemp plant parts;
(11) “Tetrahydrocannabinolic acid” or “THCa” is the precursor of delta-9 THC;
(12) “THC” means a tetrahydrocannabinol, tetrahydrocannabinolic acid, a THC component, or any derivative thereof;
(13) “THC component” means a naturally occurring cannabinoid component of industrial hemp or hemp;
(14) “Total THC” means a hemp-derived cannabinoid or a combination of tetrahydrocannabinol, tetrahydrocannabinolic acid, a THC component, or a derivative thereof;
(15) “Total theoretical tetrahydrocannabinol content” or “total theoretical THC content” is the maximum amount of possible delta-9 tetrahydrocannabinol if total conversion were to occur, calculated as the sum of the concentration of delta-9 tetrahydrocannabinol added to the amount of tetrahydrocannabinolic acid after such amount is multiplied by eight hundred seventy-seven thousandths (0.877) on a dry weight basis and reported to two (2) significant figures, and expressed in a mathematical formula as follows:Total theoretical THC = ([delta 9 THC] + ([THCa] x 0.877)); and
Total theoretical THC = ([delta 9 THC] + ([THCa] x 0.877)); and
(16) “Wholesaler” means a person that purchases finished and packaged for consumption HDCPs, not considered intermediate products still in the pre-packaging stage, from suppliers licensed under this chapter, or from other wholesalers licensed under this chapter, and that sells HDCPs for resale and not for consumption.